Syndrome of body fat redistribution in HIV‐1‐infected patients: relationships to cortisol and catecholamines
Authors:
- 1 August 1999
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 51 (2) , 223-230
Abstract
OBJECTIVE: Alterations of body fat distribution have been recently reported in HIV‐infected patients. We aimed to investigate whether the hormones modulating adipose tissue metabolism could be implicated.SUBJECTS: We investigated twenty‐eight HIV‐infected patients who had developed abdominal fat, combined with peripheral lipodystrophy in 25 cases and ‘buffalo hump’ in 2 cases, but who had otherwise improved on antiretroviral therapies. Twelve patients with no change in body fat, matched for age, disease control and treatment, were studied as controls.MEASUREMENTS: Body composition was assessed by bioelectrical impedance analysis. Subcutaneous (SAT) and visceral (VAT) compartments of total abdominal adipose tissue (TAT) were measured by computed tomography. Resting metabolic rate (RMR) was assessed by indirect calorimetry. Endocrine investigations included plasma thyroid hormones, cortisol, testosterone, oestradiol and 24‐hour urinary free cortisol (UFC) and catecholamines.RESULTS: Despite similar body mass index, the patients with body fat alterations showed significantly larger VAT and higher VAT:TAT ratio than controls (P = 0.002 and 0.0001, respectively). In these patients, RMR was significantly higher than estimated according to the Harris‐Benedict formula (+ 19.7 ± 11.6 %, P = 0.0001) and correlated with VAT (r = 0.58, P = 0.003) and 24‐hour urinary output of catecholamines (r = 0.67, P = 0.002), that was significantly increased in comparison withcontrols (1737 ± 1228 vs 476 ± 292 nmol, P = 0.013). We also found a significant correlation between VAT and UFC (r = 0.41, P = 0.042) that was absent in controls, although levels of UFC were similar in the two groups.CONCLUSIONS: Our data suggest that body fat redistribution may involve cortisol and catecholamine actions. While high release of catecholamines may enhance RMR through increased lipolysis, cortisol may promote central fat storage. These effects might be related both to persistent hormonal responses to stress becoming inappropriate while disease control improved and to an increased sensitivity of visceral adipose tissue to cortisol in affected patients.Keywords
This publication has 38 references indexed in Scilit:
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Stress-Related Cortisol Secretion in Men: Relationships with Abdominal Obesity and Endocrine, Metabolic and Hemodynamic AbnormalitiesThe Journal of Clinical Endocrinology & Metabolism, 1998
- Effects of Physiological Hypercortisolemia on the Regulation of Lipolysis in Subcutaneous Adipose TissueThe Journal of Clinical Endocrinology & Metabolism, 1998
- Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoidsEndocrine Reviews, 1996
- Hypothalamo-pituitary-adrenal function in human immunodeficiency virus- infected menThe Journal of Clinical Endocrinology & Metabolism, 1996
- Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapyThe Journal of Clinical Endocrinology & Metabolism, 1994
- Increased de novo hepatic lipogenesis in human immunodeficiency virus infectionThe Journal of Clinical Endocrinology & Metabolism, 1993
- Cortisol resistance in acquired immunodeficiency syndromeThe Journal of Clinical Endocrinology & Metabolism, 1992
- Physiologic Basis for the Control of Body Fat Distribution in HumansAnnual Review of Nutrition, 1989
- Physiologic Basis For The Control Of Body Fat Distribution In HumansAnnual Review of Nutrition, 1989